FDC Ltd Profit & Loss Annual

BSE: 531599 | NSE: FDC | ISIN: INE258B01022 | Sector: Biotechnology & Drugs

349.50 +8.65 (2.54%)Updated : 15 Sep 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	1,904.87	1,837.05	1,644.32	1,571.72
Other Net	6.27	1.99	-0.06	0.99
Diluted Weighted Average Shares	16.28	16.28	16.42	16.62
Gain( Loss)on Saleof Assets	24.26	4.26	4.48	0.91
Depreciation/ Amortization	59.24	53.73	39.92	38.94
Operating Income	266.07	271.07	298.62	212.04
Net Income	281.42	266.79	305.22	194.04
Income Availableto Com Excl Extra Ord	281.42	266.79	305.22	194.04
Other Operating Expenses Total	24.59	24.43	20.96	17.03
Net Income Before Taxes	374.60	357.22	396.22	257.80
Net Income After Taxes	281.42	266.79	305.06	193.83
Income Availableto Com Incl Extra Ord	281.42	266.79	305.22	194.04
Costof Revenue Total	823.55	831.99	756.82	747.12
Gross Profit	1,347.38	1,276.13	1,186.12	1,036.63
Interest Inc( Exp) Net- Non- Op Total	78.00	79.90	93.18	43.87
Unusual Expense( Income)	20.79	-	-	-
Diluted Net Income	281.42	266.79	305.22	194.04
Provisionfor Income Taxes	93.18	90.43	91.16	63.98
period Type	-	-	-	-
Net Income Before Extra Items	281.42	266.79	305.22	194.04
Total Revenue	2,170.93	2,108.12	1,942.94	1,783.75
period Length	12.00	12.00	12.00	12.00
Revenue	2,170.93	2,108.12	1,942.94	1,783.75
Selling/ General/ Admin Expenses Total	950.58	918.71	808.15	751.53
Diluted Normalized EPS	17.12	16.19	18.38	11.63
Research Development	26.11	8.20	18.48	17.10
Diluted EPS Excluding Extra Ord Items	17.29	16.39	18.59	11.67
Minority Interest	-	0.00	0.16	0.21
DPS- Common Stock Primary Issue	-	5.00	-	-